Skip to main content
NAGE logo

NAGE · Niagen Bioscience, Inc. · Executive Compensation

Track NAGE — free
$3.05 -0.05 (-1.61%) At close · Sep 9
Market Cap
$242.01M
Shares
79.13M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Robert Fried $8,381,900
Fiscal 2024
Executive Total
Robert Fried $1,212,131
Ozan Pamir $461,641
Brianna Gerber $450,969
James Lee $374,470
Carlos Lopez $347,637
Fiscal 2023
Executive Total
Robert Fried $1,160,206
Brianna Gerber $691,588
Fiscal 2022
Executive Total
Robert Fried $1,158,850
Brianna Gerber $842,384
Kevin Farr $839,537
Frank Jaksch $482,354
Fiscal 2021
Executive Total
Robert Fried $1,103,160
Lisa Harrington $1,037,785
Frank Jaksch $694,559
Kevin Farr $626,429
Fiscal 2020
Executive Total
Robert Fried $1,126,685
Frank Jaksch $734,678
Kevin Farr $688,816
Fiscal 2019
Executive Total
Robert Fried $1,711,894
Frank Jaksch $636,778
Kevin Farr $621,503

Executive changes

Person Change Filed
Hamed Shahbazi Appointed 2025-06-27
Ann Cohen Appointed 2025-06-27
Kristin Patrick Appointed 2025-06-27
Gary Ng Appointed 2025-06-27
Wendy Yu Appointed 2025-06-27
Steven Rubin Appointed 2025-06-27
Robert Fried Appointed 2025-06-27
Frank L. Jaksch Jr. Appointed 2025-06-27
Key facts CIK 1386570 CUSIP 171077407 13F (30d) 88 filings 88 filers Visit website Investor relations